Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets ...
Winners leverage the MQTT protocol for positive outcomes and business value in manufacturing, life sciences and healthcare.
ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections, shrugging off worries popular weight-loss drugs from Novo Nordisk and Eli Lilly would hammer its top ...